Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Bacteriology

Novel Single-Tube Agar-Based Test System for Motility Enhancement and Immunocapture of Escherichia coli O157:H7 by H7 Flagellar Antigen-Specific Antibodies

Shelton E. Murinda, Lien T. Nguyen, Susan J. Ivey, Raul A. Almeida, Stephen P. Oliver
Shelton E. Murinda
The University of Tennessee Food Safety Center of Excellence, Knoxville, Tennessee 37996
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lien T. Nguyen
The University of Tennessee Food Safety Center of Excellence, Knoxville, Tennessee 37996
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan J. Ivey
The University of Tennessee Food Safety Center of Excellence, Knoxville, Tennessee 37996
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raul A. Almeida
The University of Tennessee Food Safety Center of Excellence, Knoxville, Tennessee 37996
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen P. Oliver
The University of Tennessee Food Safety Center of Excellence, Knoxville, Tennessee 37996
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: soliver@utk.edu
DOI: 10.1128/JCM.40.12.4685-4690.2002
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

This paper describes a novel single-tube agar-based technique for motility enhancement and immunoimmobilization of Escherichia coli O157:H7. Motility indole ornithine medium and agar (0.4%, wt/vol) media containing either nutrient broth, tryptone broth, or tryptic soy broth (TSBA) were evaluated for their abilities to enhance bacterial motility. Twenty-six E. coli strains, including 19 O157:H7 strains, 1 O157:H− strain, and 6 generic E. coli strains, were evaluated. Test bacteria were stab inoculated in the center of the agar column, and tubes were incubated at 37°C for 18 to 96 h. Nineteen to 24 of the 26 test strains (73.1 to 92.3%) were motile in the different media. TSBA medium performed best and was employed in subsequent studies of motility enhancement and H7 flagellar immunocapture. H7 flagellar antiserum (30 and 60 μl) mixed with TSBA was placed as a band (1 ml) in the middle of an agar column separating the top (3-ml) and bottom (3-ml) agar layers. The top agar layer was inoculated with the test bacterial strains. The tubes were incubated at 37°C for 12 to 18 h and for 18 to 96 h. The specificity and sensitivity of the H7 flagellar immunocapture tests were 75 and 100%, respectively. The procedure described is simple and sensitive and could be adapted easily for routine use in laboratories that do not have sophisticated equipment and resources for confirming the presence of H7 flagellar antigens. Accurate and rapid identification of H7 flagellar antigen is critical for the complete characterization of E. coli O157:H7, owing to the immense clinical, public health, and economic significance of this food-borne pathogen.

Enterohemorrhagic Escherichia coli (EHEC) O157:H7 is the most commonly identified member of the Shiga-toxin-producing E. coli family involved in human food-borne illnesses (2, 12). EHEC O157:H7 was first implicated in human diarrheal disease in 1982 (7). EHEC O157:H7 has immense clinical, public health (9), and economic significance, as indicated by the USDA Economic Research Service (http://www.ers.usda.gov/emphases/safefood/features.htm ).

The spectrum of diseases or conditions caused by EHEC O157:H7 includes asymptomatic infection, mild uncomplicated diarrhea, hemolytic colitis, diarrhea-associated hemolytic-uremic syndrome, diarrhea-associated thrombotic thrombocytopenic purpura, and, in some cases, death (2, 7, 12).

Positive identification of EHEC O157:H7 is commonly made by biochemical confirmation of E. coli isolates, O157 serology, and detection of the H7 flagellar antigen by agglutination with H7-specific antiserum. Presumptively positive isolates are further confirmed by genetic methods, such as PCR and pulsed-field gel electrophoresis. Fields et al. (3) reported that clinical isolates may be motile and may react with H7 antisera or they may not react with antisera because they are either nonmotile (NM or H−) or motile but do not react with typing sera (H undetermined).

H7 is one of 53 flagellar antigen groups described for E. coli (3, 13). In conventional detection methodologies, determination of the H7 flagellar antigen phenotype is usually performed with presumptively positive E. coli O157 colonies isolated from selective or differential medium to confirm that an isolate is of the H7 serogroup (6). With some isolates, confirmation of H7 serology may be delayed because multiple passages in motility enhancement medium may be required before the flagellar antigen is expressed sufficiently to be detectable in O157 colonies isolated from selective or differential medium, as described by the Centers for Disease Control (http://wonder.cdc.gov/wonder/PrevGuid/p0000445/p0000445.asp ). For example, the E. coli Reference Center (The Pennsylvania State University, State College, Pa. [C. DebRoy, personal communication ]) incubates colonies for 10 days before strains are designated as nonmotile. Ware et al. (14) recently reported a preponderance of aberrant isolates of E. coli O157:H7, demonstrating unusual biochemical reactions, that required 4 to 17 passages in vitro before the presence of H7 antigen could be demonstrated serologically.

The detection of O157 antigens independent of H7 antigens is insufficient for the identification of EHEC O157:H7. Critical detection of EHEC O157:H7 relies on demonstration of both somatic (O157) and flagellar (H7) antigens. These diagnostic steps are necessary to avoid false-positive misidentification of other enteric bacteria as EHEC O157:H7, such as other E. coli serotypes, Escherichia hermanii, Yersinia enterocolitica, Salmonella group N spp., Brucella abortus, Vibrio cholerae O1, and some Citrobacter spp. (11, 14). Misdiagnosis can be very costly in terms of the loss of recalled or withdrawn perishable food products, the death of patients, and litigation.

While determination of O157 serology by using commercially available antisera is a simple and straightforward process, many laboratories cannot easily perform H7 serology because of the relative complexity of the test; thus, they rely on reference laboratories to perform the costly tests (3).

The objective of this study was to develop a simple, inexpensive, reliable, and specific method that allows both enhancement of motility and detection of H7 flagellar antigen and that is amenable to routine use in a small clinical or food microbiology laboratory. The test was designed to provide serological confirmation of the identity of E. coli O157:H7 isolates. The method described herein does not require great technical expertise or elaborate equipment. The long-term goal is to apply the method to the development of pathogen reduction programs for rapid identification of E. coli O157:H7 and possibly for adaptation to other EHEC serotypes of interest.

MATERIALS AND METHODS

Maintenance of bacterial cultures.The test bacterial strains (Table 1) evaluated in this study consisted of O157:H7 strains (n = 19), an O157:H− strain (n = 1), generic E. coli strains (n = 6), and Escherichia vulneris (n = 1). Salmonella enterica serovars (n = 4) were used as negative controls for reaction with H7 antiserum and as positive motility controls. Working stock cultures were maintained as slants on tryptic soy agar containing 0.6% (wt/vol) yeast extract at 5°C for 1 month. For long-term storage, Escherichia and Salmonella strains were grown in tryptic soy broth and lactose broth, respectively, for 24 h at 37°C, after which the cultures were mixed with 25% glycerol (1:1, vol/vol) and stored at −80°C.

View this table:
  • View inline
  • View popup
TABLE 1.

Bacterial strains used in this study

Evaluation of motility test media.Four media (see Table 2), motility indole ornithine (MIO) medium and agar (0.4%, wt/vol) media containing either nutrient broth (NBA), tryptone broth (TBA), or tryptic soy broth (TSBA) were evaluated for their ability to enhance motility of inoculated test bacteria. Six milliliters of the respective motility medium was dispensed into test tubes. Cultures propagated in broth at 37°C for 18 h (about 108 CFU/ml) were stab inoculated into the center of the agar column. Tubes were incubated at 37°C for 12, 18, 24, 48, and 96 h to establish optimum incubation times. Sixteen E. coli cultures grown in NBA and MIO media at 42°C were used to assess the effect of elevated incubation temperature on motility enhancement. Motility was manifested as clouding of the growth medium that progressed laterally and downwards from the stab inoculation line. Salmonella enterica serovars were used as positive motility controls, whereas nonmotile (H−) E. coli strains (n = 4) were employed as negative controls (Table 1). Growth was scored visually and coded with scores of 0, 1, 2, 3 and 4 to indicate no growth beyond the line of stab inoculation (score = 0) to luxuriant growth throughout the culture medium (score = 4).

View this table:
  • View inline
  • View popup
TABLE 2.

Representative motility scores of E. coli isolates at 37°C after incubation for 18 and 96 h

Preparation of single-tube motility and H7 flagellar immunocapture test media.TSBA was the best motility enhancement medium in terms of level of bacterial growth, ease of reading results, and lack of false-positive motile strains. It was therefore used in subsequent studies. Three-milliliter aliquots of agar were dispensed into test tubes that were then autoclaved (121°C for 15 min). A portion of the tube contents was allowed to gel at room temperature, while other tubes were tempered in a water bath at 50°C. The tubes were withdrawn from the water bath, and 30 μl of polyclonal, monovalent, H7 flagellar antigen-specific Denka Seiken E. coli antiserum (Oxoid Inc., Nepean, Ontario, Canada; catalog no. 211057, lot no. 26-111A) was added to 1 ml of TSBA medium. In a parallel experiment, the effect of using 60 μl of antiserum was evaluated. The contents of the tubes were vortexed for about 2 s, after which 1-ml aliquots were dispensed into tubes containing 3 ml of gelled bottom agar, as illustrated in Fig. 1. For controls, the antiserum solution was replaced by 30 or 60 μl of sterile saline solution (0.85% [wt/vol] NaCl). After the middle agar layer gelled (∼15 min), 3 ml of tempered TSBA medium (50°C) was gently added along the side of the tube. The tubes were allowed to gel and cool at room temperature before they were used.

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

Schematic showing preparation and inoculation of single-tube agar-based test system. The principle of the method is that the enhancement of motility by TSB (0.4% [wt/vol] agar) medium and subsequent immunocapture of H7 flagellated bacteria in the middle agar layer containing H7 flagellar-specific antibodies result in retardation or stoppage of motility through the middle agar layer.

Motility and flagellar immunocapture tests.As before, motility-positive and nonmotile controls were employed. Actively growing test cultures (Table 1) in broth (37°C) were stab inoculated into two tubes each, i.e., without antiserum (saline control) and with antiserum. The inoculating needle was stabbed straight down the center of the TSBA column, extending two-thirds down the upper agar layer as illustrated in Fig. 1. The tubes were incubated at 37°C, which had been established as the optimum temperature for motility of the test strains. After 12 to 18 h of incubation, the tubes were scored for development of cloudiness (indicating growth) in the top, middle, and bottom agar layers.

Interpretation of motility and immunocapture tests.Growth in the top, middle, and bottom agar layers was scored independently by using the same criteria employed for the motility media described above. For documentation, the tubes were photographed with a digital camera (model CoolPix 990, 3.34 Megapixel; Nikon, Tokyo, Japan); images were transferred to a computer and stored as JPEG (joint photographers expert group) files that were imported into PowerPoint 2000 (Microsoft Corp., Redmond, Wash.).

RESULTS

Preliminary motility evaluation studies.Ten of 16 E. coli strains that were evaluated for motility at 42°C for 48 h were motile in MIO medium, whereas only one strain was motile in NBA medium. After incubation was extended to 5 days, 14 and 5 strains were motile in MIO and NBA media, respectively, and 2 of the test strains were nonmotile (data not shown). Bacterial cultures demonstrated a greater number of motile strains and more extensive growth at 37°C than at 42°C; 13 of 16 strains cultured in NBA medium and 14 of 16 strains cultured in MIO medium demonstrated motility (data not shown).

Motility evaluation at 37°C.Results of motility tests conducted at 37°C in NBA, TBA, TSBA, and MIO media were compared after the strains were incubated for 18, 24, 48, and 96 h. A greater number of test strains (Tables 2 and 3) demonstrated motility in TSBA and MIO media (20 of 26 and 24 of 26, respectively) than in TBA and NBA media (19 of 26 and 21 of 26, respectively). The strains incubated for 96 h showed improved motility in NBA and TBA media but only slight improvement in TSBA and MIO media. Salmonella serovars grew luxuriantly in the four media evaluated (data not shown). Greater growth vigor was demonstrated in TSBA and MIO media, with MIO medium yielding four more strains that were scored as motile than TSBA medium did (Tables 2 and 3). MIO medium encouraged motility of E. coli strain ATCC 23513 and apparent motility of nonmotile E. coli strains ATCC 12014, ATCC 23545, and ATCC 31619; these isolates were nonmotile in NBA, TBA, and TSBA media. The E. coli O157:H7 ground beef isolate did not exhibit motility in NBA, TBA, or TSBA medium after 18 h of incubation. The longer incubation time of 96 h encouraged motility of the ground beef isolate in the three media and yielded more strains that were scored as motile in MIO and NBA media. However, strains demonstrating new motility at 96 h were not numerous. The results indicate that longer incubation times may increase the number of motile strains. None of the media evaluated enhanced the motility of the E. coli O157:H7 isolate from cider or the nonmotile E. coli O157:H7 strain ATCC 700375 even after incubation was extended to 96 h.

View this table:
  • View inline
  • View popup
TABLE 3.

Motility test results in different mediaa

Escherichia vulneris and S. enterica serovars. S. enterica serovar Typhimurium ATCC 14028, serovar Anatum ATCC 9270, and serovar Newport ATCC 6962 grew luxuriantly in the four media evaluated. However, Salmonella serovar Muenchen ATCC 8388 occasionally did not demonstrate good growth (data not shown). Although the levels of motility enhancement were comparable in all media, TSBA and MIO media showed the best growth promotion. However, motility results were easier to read and interpret in TSBA medium (Fig. 2). MIO medium yields growth in variegated colors, i.e., mixtures of purple, white, and yellow, depending on the test bacterial strain. This could confound interpretation of motility with pH or other changes, leading to false-positive motility results. Although MIO medium had higher sensitivity for motility enhancement than TSBA, TBA, and NBA media (95.45 versus 90.91%), its specificity was 50 to 75% lower than those of the other media (Table 3). TSBA medium was thus selected for use in further studies of the development of a single-tube agar-based test for both motility enhancement and H7 flagellar immunocapture.

FIG. 2.
  • Open in new tab
  • Download powerpoint
FIG. 2.

Representative tubes showing motility of E. coli O157:H7 strains on MIO and TSBA media. Tube 1 indicates a motility score of 4 in MIO medium and also demonstrates the variegated or hazy appearance of this medium. Tubes 2, 3, and 4 show growth in TSBA medium with growth scores of 4, 3, and 2, respectively.

H7 flagellar immunocapture tests. Salmonella strains grew luxuriantly in both test and saline control TSBA tubes (data not shown). Figure 3 shows representative motility and immunocapture reactions for E. coli O157:H7 strains 36E1 and ATCC 43894. Both strains grew throughout the saline control tube; however, growth was retarded in the tubes containing H7 antiserum in the middle agar layer. At times, slight growth was found in the middle agar layer but the specific reaction of H7 bacteria and antibodies was evident. A sharply defined, and usually convex-concave interphase, appeared between the leading edge of advancing bacterial growth and the H7 antiserum-containing middle agar layer.

FIG. 3.
  • Open in new tab
  • Download powerpoint
FIG. 3.

Representative tubes showing reactions of E. coli O157:H7 with H7 antiserum adsorbed in the middle agar layer. (A) E. coli O157: H7 strain 36E1. Tubes 5 and 6 contain 30 μl of sterile saline solution (0.85% [wt/vol] NaCl) and 30 μl of H7 antiserum, respectively, per ml of TSBA medium. Tubes 7 and 8 contain 60 μl of saline solution and 60 μl of H7 antiserum, respectively, per ml of TSBA medium. Greater growth retardation is demonstrated in tube 8. (B) E. coli O157:H7 strain ATCC 43894. Tubes 9 and 10 contain 30 μl of sterile saline solution (0.85% [wt/vol] NaCl) and 30 μl of H7 antiserum, respectively, per ml of TSBA medium. Tubes 11 and 12 contain 60 μl of saline solution and 60 μl of H7 antiserum, respectively, per ml of TSBA medium. Greater growth retardation is demonstrated in tube 12.

Gas bubbles were present at times in the motility media (Fig. 3); these could confound interpretation of motility and binding results or cause breakage at the interfaces of agar layers. However, refrigeration of tubes at 5°C (∼30 min) and/or gentle tapping of tubes on the bench top improved the reading of results since dissipation of the formed bubbles enabled visualization of bacterial growth boundaries.

Specificity and sensitivity of immunocapture tests.The specificities and sensitivities of the tests were determined by using E. coli O157, H7, and H− variants, generic E. coli, E. vulneris, and S. enterica serovars. Specificity was determined by dividing the number of true negatives by the number of true negatives plus the number of false positives and multiplying the result by 100. Sensitivity was determined by dividing the number of true positives by the number of true positives plus the number of false negatives and multiplying the result by 100. The use of 60 μl of antiserum in place of 30 μl per ml of TSBA middle agar layer improved both sensitivity and specificity measures for validating immunocapture of E. coli O157:H7 by adsorbed H7 flagellar antibodies (specificities, 55.5 and 75%; sensitivities, 92 and 100% [with 30 and 60 μl, respectively]). The specificity and sensitivity improved by about 19.5 and 7.7%, respectively.

DISCUSSION

The development of methods for accurate and rapid detection of E. coli O157:H7 is an important area of research internationally. The present study evaluated motility enhancement media and H7 flagellar immunocapture by using a single-tube agar-based test system. The principle of this assay is that motile bacteria inoculated at the top of a semisolid agar column grow and migrate downwards towards a zone that contains adsorbed H7 flagellated antigen-specific antibodies. Flagellar antigens present on the bacteria bind to antibodies, and captured bacteria display a visible zone demarcating stoppage or retardation of growth. The adsorbed H7 antibodies retained antigen recognition properties as indicated by test strains used as positive and negative controls.

The described test system was used to confirm pure cultures of H7 flagellar E. coli O157 strains within 12 to 18 h. Longer incubation times might be required to encourage the motility of some strains. Bacteria vary in their expression of flagellar antigens, and therefore it is sometimes necessary to serially passage them through motility agar media (14) or to extend incubation times in order to enhance motility (11, 14). Ware et al. (14) reported a large number of E. coli O157:H7 isolates that remained nonmotile even after 96 h of incubation at 37°C. The E. coli Reference Center (The Pennsylvania State University) protocol uses an extended incubation of up to 10 days to enhance motility. The media evaluated in the present study failed to enhance the motilities of E. coli O157:H7 isolated from cider and E. coli O157:H7 strain ATCC 700375, even after incubation was extended to 96 h. The latter strain is nonmotile, whereas the isolate from cider was demonstrated to be H7 positive by use of latex agglutination tests and tests for the presence of H7 flagellar gene-encoding sequences (10). Other nonmotile E. coli strains, ATCC 31619, ATCC 12014, and ATCC 23545, demonstrated apparent motility in MIO medium but were nonmotile in TSBA, NBA, and TBA media.

Specificity and sensitivity validations of H7 flagellar antigen immunocapture were increased by about 19.5 and 7.7%, respectively, by increasing the H7 antiserum content from 30 to 60 μl/ml of TSBA medium. The large increment in specificity seems to indicate that the level of antibodies in the agar matrix was not optimal when 30 μl of antiserum/ml of TSBA medium was used. This may partially explain why in some instances there was limited growth of H7 flagellated bacteria in the antiserum-containing middle agar layer. Growth could have been due to saturation of the available binding sites, resulting in free passage of unadsorbed motile bacteria that grew in the middle agar layer and continued growth in the bottom agar layer. Known positive and negative controls were employed to ascertain the validity of the tests; the absence of spontaneous reaction was tested by using physiological saline in place of H7 flagellar antiserum.

Comparable antigen-antibody procedures that employed agar gel matrices that eliminated the need to establish optimal proportions of antigens and antibodies in immunoprecipitation studies have been reported (8). Farmer and Davis (1) described a single-tube screening medium for detecting E. coli O157:H7. The system was based on sorbitol fermentation and the presence of H7 antiserum throughout the growth medium. Bacterial immobilization by H7 antiserum was indicated by failure of the test strain to migrate from the stab inoculation line. Our test system first enabled luxuriant growth of potentially motile bacterial strains and their uninterrupted downward motility through an antiserum-free agar column; then H7 flagellated E. coli bacteria were immobilized by antibodies in a horizontal layer of soft agar placed in the middle of the agar column. The test described by Farmer and Davis (1) contained antibodies that were uniformly distributed throughout a soft agar (0.4%, wt/vol) medium.

The greater growth and diffusion in MIO medium than in the other media evaluated can be partly explained by the lower concentration of agar present (0.2%, wt/vol), which formed a network of large pores allowing freer movement of bacteria within the gel matrix. NBA, TBA, and TSBA media contained higher agar concentrations (0.4%, wt/vol). Our observations indicate that movement of bacteria within the agar matrix is largely a function of motility of the growing bacteria.

An advantage of the single-tube agar-based test system is that it is a contained test. After culturing for motility, there is no need for secondary handling of bacteria to conduct H7 serology. Additionally, the test avoids the difficulties of reading slide- or test tube-based agglutination reactions which require separate motility enhancement procedures. Bubbles that occasionally formed in motility test media were ascribed to the presence of fermentable sugar, which was metabolized during gas production. It is possible to reduce the bubbling phenomenon by constructing media devoid of a fermentable sugar carbon source.

In many field and clinical studies, the services of a reference laboratory are required for flagellar serotyping since there is currently no easy method to confirm the presence or absence of H7 phenotypes in E. coli isolates (5). Flagellar H7 gene sequences, and polymorphisms thereof, are often found in nonmotile E. coli O157 strains (3, 4, 13) and in about 10% of non-O175 E. coli strains (1). Accurate identification of H7 flagellar antigen is critical for the confirmation of the identity of E. coli O157:H7 strains, in distinguishing them from (benign) nonmotile strains, for determining the specificity of the PCR methods used in detecting the toxin gene-containing sequences, and for correlating the presence of a gene with phenotypic expression. Such information is relevant to detailed taxonomic and epidemiological studies and for purposes of timely and appropriate clinical intervention and release or recall of products from the market.

The single-tube method described can be extended to evaluation of motility and flagellar antigen-specific immunocapture of other serotypes of Shiga-toxin-producing E. coli by using relevant flagellar antisera of strains of interest.

The present study addressed the development of a practical and cost-effective single-tube agar-based test system for enhancement of motility followed by immunoimmobilization of motile E. coli O157:H7 by H7-specific antibodies. There is the potential for routine use of this method in small clinical or food microbiology laboratories. The system developed has high sensitivity (100%) and specificity (75%) and includes, in a single assay, both motility enhancement and subsequent detection of H7-flagellated E. coli O157 isolates.

ACKNOWLEDGMENTS

This investigation was supported by The University of Tennessee Food Safety Center of Excellence.

We thank Mark Lewis for technical assistance and David Golden for supplying some of the E. coli O157:H7 quality control strains used in this study.

FOOTNOTES

    • Received 22 April 2002.
    • Returned for modification 31 May 2002.
    • Accepted 11 September 2002.
  • Copyright © 2002 American Society for Microbiology

REFERENCES

  1. 1.↵
    Farmer, J. J., III, and B. R. Davis. 1985. H7 antiserum-sorbitol fermentation medium: a single tube screening medium for detecting Escherichia coli O157:H7 associated with hemorrhagic colitis. J. Clin. Microbiol.22:620-625.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    Fey, P. D., R. S. Wickert, M. E. Rupp, T. J. Safranek, and S. H. Hinrichs. 2000. Prevalence of non-O157:H7 Shiga toxin-producing Escherichia coli in diarrheal stool samples from Nebraska. Emerg. Infect. Dis.6:530-533.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    Fields, P. I., K. Blom, H. J. Hughes, L. O. Helsel, P. Feng, and B. Swaminathan. 1997. Molecular characterization of the gene encoding H antigen in Escherichia coli and development of a PCR-restriction fragment length polymorphism test for identification of E. coli O157:H7 and O157:NM. J. Clin. Microbiol.35:1066-1070.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    Fratamico, P. M., L. K. Bagi, and T. Pepe. 2000. A multiplex polymerase chain reaction assay for rapid detection and identification of Escherichia coli O157:H7 in foods and bovine feces. J. Food Prot.63:1032-1037.
    OpenUrlPubMedWeb of Science
  5. 5.↵
    He, Y., J. E. Keen, R. B. Westerman, E. T. Littledike, and J. Kwang. 1996. Monoclonal antibodies for detection of the H7 antigen of Escherichia coli. Appl. Environ. Microbiol.62:3325-3332.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    Hitchins, A. D., P. Feng, W. D. Watkins, S. R. Rippey, and L. A. Chandler. 1998. Escherichia coli and the coliform bacteria, p. 4.01-4.29. In Food and Drug Administration bacteriological analytical manual, 8th ed., revision A. AOAC International, Gaithersburg, Md.
  7. 7.↵
    Karmali, M. A. 1989. Infection by verocytotoxin-producing Escherichia coli. Clin. Microbiol. Rev.2:15-38.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    Lam, J. S., and L. M. Mutharia. 1994. Antigen-antibody reactions, p. 104-132. In P. Gerhardt, R. G. E. Murray, W. A. Wood, and N. R. Krieg (ed.), Methods for general and molecular bacteriology. American Society for Microbiology, Washington, D.C.
  9. 9.↵
    Mead, P. S., L. Slutsker, V. Dietz, L. F. McCaig, J. S. Bresee, C. Shapiro, P. M. Griffin, and R. V. Tauxe. 1999. Food-related illness and death in the United States. Emerg. Infect. Dis.5:607-625.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    Murinda, S. E., L. T. Nguyen, S. J. Ivey, B. E. Gillespie, R. A. Almeida, F. A. Draughon, and S. P. Oliver. 2002. Prevalence and molecular characterization of Escherichia coli O157:H7 in bulk tank milk and fecal samples from cull cows: a 12-month survey of dairy farms in East Tennessee. J. Food Prot.65:752-759.
    OpenUrlCrossRefPubMed
  11. 11.↵
    Sowers, E. G., J. G. Wells, and N. A. Strockbine. 1996. Evaluation of commercial latex reagents for identification of O157 and H7 antigens of Escherichia coli. J. Clin. Microbiol.34:1286-1289.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    Sussman, M. 1997. Escherichia coli: mechanisms of virulence. Cambridge University Press, Cambridge, United Kingdom.
  13. 13.↵
    Wang, L., D. Rothemund, H. Curd, and P. R. Reeves. 2000. Sequence diversity of the Escherichia coli H7 fliC genes: implication for a DNA-based typing scheme for E. coli O157:H7. J. Clin. Microbiol.38:1786-1790.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    Ware, J. M., S. L. Abbott, and J. M. Janda. 2000. A new diagnostic problem: isolation of Escherichia coli O157:H7 strains with aberrant biochemical properties. Diagn. Microbiol. Infect. Dis.38:185-187.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
Download PDF
Citation Tools
Novel Single-Tube Agar-Based Test System for Motility Enhancement and Immunocapture of Escherichia coli O157:H7 by H7 Flagellar Antigen-Specific Antibodies
Shelton E. Murinda, Lien T. Nguyen, Susan J. Ivey, Raul A. Almeida, Stephen P. Oliver
Journal of Clinical Microbiology Dec 2002, 40 (12) 4685-4690; DOI: 10.1128/JCM.40.12.4685-4690.2002

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Novel Single-Tube Agar-Based Test System for Motility Enhancement and Immunocapture of Escherichia coli O157:H7 by H7 Flagellar Antigen-Specific Antibodies
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Novel Single-Tube Agar-Based Test System for Motility Enhancement and Immunocapture of Escherichia coli O157:H7 by H7 Flagellar Antigen-Specific Antibodies
Shelton E. Murinda, Lien T. Nguyen, Susan J. Ivey, Raul A. Almeida, Stephen P. Oliver
Journal of Clinical Microbiology Dec 2002, 40 (12) 4685-4690; DOI: 10.1128/JCM.40.12.4685-4690.2002
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Antigens, Bacterial
Escherichia coli O157
Movement

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X